Precision BioSciences Inc (STU:PBS0)
€ 7.7 -0.05 (-0.65%) Market Cap: 59.55 Mil Enterprise Value: -6.13 Mil PE Ratio: 140.33 PB Ratio: 0.97 GF Score: 38/100

Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference Call Transcript

Apr 15, 2021 / 09:00PM GMT
Operator

Good day and thank you for standing by. Welcome to the Precision Regains Global Commercial Rights to CAR T Programs Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions). I would now like to hand the conference over to your speaker today, Alex Kelly, Interim Chief Financial Officer and Corporate Affairs Officer. Please go ahead.

Alex Kelly
Precision BioSciences - Interim CFO & Corporate Affairs Officer

Thank you, Gigi. And good afternoon, everyone, and welcome to our webcast to discuss our agreement with Servier to reacquire rights to our CAR T programs.

Before we begin, I would like to remind you that the statements we make today on this webcast do not relate to matters of historical fact or future -- [or our] future expectations and forward-looking statements.

Our forward-looking statements are within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot